The diagnostic value of CRP, IL-8, PCT, and sTREM-1 in the detection of bacterial infections in pediatric oncology patients with febrile neutropenia

Supportive Care in Cancer

Volumn 19, Issue 10, 2011, Pages 1593-1600

  Miedema, Karin G E ^a   De Bont, Eveline S J M ^a   Elferink, Rob F M Oude ^b   Van Vliet, Michel J ^a   Nijhuis, Claudi S M Oude ^a   Kamps, Willem A ^a   Tissing, Wim J E ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b MARTINI HOSPITAL   (Netherlands)

Author keywords

Bacterial infection; Biomarkers; Children; Febrile neutropenia; Mucositis

Indexed keywords

ANTINEOPLASTIC AGENT; C REACTIVE PROTEIN; INTERLEUKIN 8; PROCALCITONIN; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1;

ADOLESCENT; ARTICLE; BACTERIAL INFECTION; CANCER PATIENT; CHILD; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE MARKER; EARLY DIAGNOSIS; FEBRILE NEUTROPENIA; FEMALE; GASTROINTESTINAL MUCOSA; HUMAN; MALE; MUCOSA INFLAMMATION; PREDICTIVE VALUE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ANTINEOPLASTIC AGENTS; BACTERIAL INFECTIONS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CALCITONIN; CHILD; FEMALE; FEVER; GASTROINTESTINAL TRACT; HUMANS; INTERLEUKIN-8; MALE; MEMBRANE GLYCOPROTEINS; MUCOSITIS; NEOPLASMS; NEUTROPENIA; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; RECEPTORS, IMMUNOLOGIC; SENSITIVITY AND SPECIFICITY;

EID: 80052430330     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-010-0987-6     Document Type: Article

References (38)

1. GP Bodey M Buckley YS Sathe EJ Freireich 1966 Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia Ann Intern Med 64 328 340 5216294 1:STN:280:DyaF28%2Fnt1OmtQ%3D%3D
2. I Hann C Viscoli M Paesmans H Gaya M Glauser 1997 A comparison of outcome from febrile neutropenic episodes in children compared with adults: results from four EORTC studies. International Antimicrobial Therapy Cooperative Group (IATCG) of the European Organization for Research and Treatment of Cancer (EORTC) Br J Haematol 99 580 588 9401070 10.1046/j.1365-2141.1997.4453255.x 1:STN:280:DyaK1c%2Fmt1ansA%3D%3D
3. WT Hughes D Armstrong GP Bodey, et al. 2002 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer Clin Infect Dis 34 730 751 11850858 10.1086/339215 (Pubitemid 34194843)
4. C Oude Nijhuis WA Kamps SM Daenen, et al. 2005 Feasibility of withholding antibiotics in selected febrile neutropenic cancer patients J Clin Oncol 23 7437 7444 16234511 10.1200/JCO.2004.00.5264 (Pubitemid 46291805)
5. H Hodgson-Viden PE Grundy JL Robinson 2005 Early discontinuation of intravenous antimicrobial therapy in pediatric oncology patients with febrile neutropenia BMC Pediatr 5 10 15904510 10.1186/1471-2431-5-10 (Pubitemid 41418297)
6. E Castagnola V Fontana I Caviglia, et al. 2007 A prospective study on the epidemiology of febrile episodes during chemotherapy-induced neutropenia in children with cancer or after hemopoietic stem cell transplantation Clin Infect Dis 45 1296 1304 17968824 10.1086/522533 (Pubitemid 351411904)
7. ME Santolaya AM Alvarez A Becker, et al. 2001 Prospective, multicenter evaluation of risk factors associated with invasive bacterial infection in children with cancer, neutropenia, and fever J Clin Oncol 19 3415 3421 11454890 1:STN:280:DC%2BD3MvgtlKmsg%3D%3D (Pubitemid 32642195)
8. RA Ammann A Hirt AR Luthy C Aebi 2003 Identification of children presenting with fever in chemotherapy-induced neutropenia at low risk for severe bacterial infection Med Pediatr Oncol 41 436 443 14515382 10.1002/mpo.10320 (Pubitemid 37229435)
9. RJ Klaassen TR Goodman B Pham JJ Doyle 2000 "Low-risk" prediction rule for pediatric oncology patients presenting with fever and neutropenia J Clin Oncol 18 1012 1019 10694551 1:STN:280:DC%2BD3c7mtVOntw%3D%3D (Pubitemid 30123777)
10. EM te Poele WJ Tissing WA Kamps ES de Bont 2009 Risk assessment in fever and neutropenia in children with cancer: What did we learn? Crit Rev Oncol Hematol 72 45 55 19195908 10.1016/j.critrevonc.2008.12.009
11. ES de Bont E Vellenga JC Swaanenburg V Fidler PJ Visser-van Brummen WA Kamps 1999 Plasma IL-8 and IL-6 levels can be used to define a group with low risk of septicaemia among cancer patients with fever and neutropenia Br J Haematol 107 375 380 10583227 10.1046/j.1365-2141.1999.01707.x (Pubitemid 29530226)
12. RA Ammann N Bodmer A Hirt, et al. 2010 Predicting adverse events in children with fever and chemotherapy-induced neutropenia: the prospective multicenter SPOG 2003 FN Study J Clin Oncol 28 12 2008 2014 20231680 10.1200/JCO.2009.25.8988
13. D Heney IJ Lewis SW Evans R Banks CC Bailey JT Whicher 1992 Interleukin-6 and its relationship to C-reactive protein and fever in children with febrile neutropenia J Infect Dis 165 886 890 1569338 10.1093/infdis/165.5.886 1:CAS:528:DyaK38Xkt1Cjt74%3D
14. JA Katz MM Mustafa RO Bash JV Cash GR Buchanan 1992 Value of C-reactive protein determination in the initial diagnostic evaluation of the febrile, neutropenic child with cancer Pediatr Infect Dis J 11 708 712 1448309 10.1097/00006454-199209000-00007 1:STN:280:DyaK3s%2FnvFSktA%3D%3D
15. C Prat JM Sancho J Dominguez, et al. 2008 Evaluation of procalcitonin, neopterin, C-reactive protein, IL-6 and IL-8 as a diagnostic marker of infection in patients with febrile neutropenia Leuk Lymphoma 49 1752 1761 18661397 10.1080/10428190802258956 1:CAS:528:DC%2BD1cXhtFant73L
16. N Mukaida 2000 Interleukin-8: an expanding universe beyond neutrophil chemotaxis and activation Int J Hematol 72 391 398 11197203 1:CAS:528: DC%2BD3MXmvF2qug%3D%3D
17. GR Stryjewski ES Nylen MJ Bell, et al. 2005 Interleukin-6, interleukin-8, and a rapid and sensitive assay for calcitonin precursors for the determination of bacterial sepsis in febrile neutropenic children Pediatr Crit Care Med 6 129 135 15730597 10.1097/01.PCC.0000149317.15274.48 (Pubitemid 40724303)
18. A Lindemann I Tamm K Tanodi R Mertelsmann 1995 Interleukin-8 serum levels for early detection of infectious episodes in neutropenic patients J Infect Dis 172 610 7622920 10.1093/infdis/172.2.610 1:STN:280:DyaK2MzkvVGkuw%3D%3D
19. M Assicot D Gendrel H Carsin J Raymond J Guilbaud C Bohuon 1993 High serum procalcitonin concentrations in patients with sepsis and infection Lancet 341 515 518 8094770 10.1016/0140-6736(93)90277-N 1:STN:280:DyaK3s7nt1yjuw%3D%3D (Pubitemid 23066085)
20. P Dandona D Nix MF Wilson, et al. 1994 Procalcitonin increase after endotoxin injection in normal subjects J Clin Endocrinol Metab 79 1605 1608 7989463 10.1210/jc.79.6.1605 1:CAS:528:DyaK2MXislWitLg%3D
21. B al Nawas PM Shah 1996 Procalcitonin in patients with and without immunosuppression and sepsis Infection 24 434 436 9007590 10.1007/BF01713044 1:CAS:528:DyaK2sXhtlOksrw%3D (Pubitemid 27023091)
22. M Hatzistilianou A Rekliti F Athanassiadou D Catriu 2009 Procalcitonin as an early marker of bacterial infection in neutropenic febrile children with acute lymphoblastic leukemia Inflamm Res 59 229 347
23. M Hochreiter T Kohler AM Schweiger, et al. 2009 Procalcitonin to guide duration of antibiotic therapy in intensive care patients: a randomized prospective controlled trial Crit Care 13 R83 19493352 10.1186/cc7903
24. A Bouchon J Dietrich M Colonna 2000 Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes J Immunol 164 4991 4995 10799849 1:CAS:528:DC%2BD3cXjt1Gltbs%3D (Pubitemid 30305166)
25. S Gibot PE Le Renard PE Bollaert, et al. 2005 Surface triggering receptor expressed on myeloid cells 1 expression patterns in septic shock Intensive Care Med 31 594 597 15754199 10.1007/s00134-005-2572-x (Pubitemid 40543894)
26. FA Rivera-Chavez JP Minei 2009 Soluble triggering receptor expressed on myeloid cells-1 is an early marker of infection in the surgical intensive care unit Surg Infect (Larchmt) 10 5 435 439 10.1089/sur.2009.030
27. C Bopp S Hofer A Bouchon JB Zimmermann E Martin MA Weigand 2009 Soluble TREM-1 is not suitable for distinguishing between systemic inflammatory response syndrome and sepsis survivors and nonsurvivors in the early stage of acute inflammation Eur J Anaesthesiol 26 504 507 19307971 10.1097/EJA.0b013e328329afca 1:CAS:528:DC%2BD1MXntVGmsb8%3D
28. J Phua ES Koay D Zhang KH Lee 2008 How well do serum sTREM-1 measurements prognosticate in septic shock? Anaesth Intensive Care 36 654 658 18853582 1:STN:280:DC%2BD1cnlvFCjsg%3D%3D
29. MJ van Vliet WJ Tissing EH Rings, et al. 2009 Citrulline as a marker for chemotherapy induced mucosal barrier injury in pediatric patients Pediatr Blood Cancer 53 1188 1194 19688831 10.1002/pbc.22210
30. WV Kern M Heiss G Steinbach 2001 Prediction of gram-negative bacteremia in patients with cancer and febrile neutropenia by means of interleukin-8 levels in serum: targeting empirical monotherapy versus combination therapy Clin Infect Dis 32 832 835 11229856 10.1086/319207 1:STN:280:DC%2BD3MvjsVGlsw%3D%3D (Pubitemid 32221947)
31. G Fleischhack I Kambeck D Cipic C Hasan U Bode 2000 Procalcitonin in paediatric cancer patients: its diagnostic relevance is superior to that of C-reactive protein, interleukin 6, interleukin 8, soluble interleukin 2 receptor and soluble tumour necrosis factor receptor II Br J Haematol 111 1093 1102 11167745 10.1046/j.1365-2141.2000.02458.x 1:STN:280:DC%2BD3M7ktFSktA%3D%3D (Pubitemid 32104921)
32. G Secmeer I Devrim A Kara, et al. 2007 Role of procalcitonin and CRP in differentiating a stable from a deteriorating clinical course in pediatric febrile neutropenia J Pediatr Hematol Oncol 29 107 111 17279007 10.1097/MPH.0b013e3180320b5b 1:CAS:528:DC%2BD2sXjt1Shtrs%3D (Pubitemid 46213857)
33. T Lehrnbecher D Venzon M de Haas SJ Chanock J Kuhl 1999 Assessment of measuring circulating levels of interleukin-6, interleukin-8, C-reactive protein, soluble Fc gamma receptor type III, and mannose-binding protein in febrile children with cancer and neutropenia Clin Infect Dis 29 414 419 10476751 10.1086/520224 1:STN:280:DyaK1MvgsVCjsw%3D%3D (Pubitemid 29380209)
34. V Nobre S Harbarth JD Graf P Rohner J Pugin 2008 Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial Am J Respir Crit Care Med 177 498 505 18096708 10.1164/rccm.200708-1238OC 1:CAS:528:DC%2BD1cXjvFyqsrk%3D (Pubitemid 351442188)
35. NM Blijlevens JP Donnelly BE DePauw 2005 Inflammatory response to mucosal barrier injury after myeloablative therapy in allogeneic stem cell transplant recipients Bone Marrow Transplant 36 703 707 16062174 10.1038/sj.bmt.1705118 1:CAS:528:DC%2BD2MXhtVGrurnE (Pubitemid 41518713)
36. MA Stokman CS Oude Nijhuis FK Spijkervet, et al. 2006 The role of oral mucositis on the systemic inflammation parameter IL-8 in febrile neutropenic cancer patients Cancer Invest 24 479 483 16939955 10.1080/07357900600814698 1:CAS:528:DC%2BD28XhtVGitrfI (Pubitemid 44576400)
37. Y Ki W Kim J Nam D Kim D Park D Kim 2009 C-reactive protein levels and radiation-induced mucositis in patients with head-and-neck cancer Int J Radiat Oncol Biol Phys 75 393 398 19362778 10.1016/j.ijrobp.2008.11.012 1:CAS:528:DC%2BD1MXhtV2ktrnM
38. AH Herbers T Feuth JP Donnelly NM Blijlevens 2010 Citrulline-based assessment score: first choice for measuring and monitoring intestinal failure after high-dose chemotherapy Ann Oncol 21 8 1706 1711 20089560 10.1093/annonc/mdp596 1:STN:280:DC%2BC3cjgslSitg%3D%3D